Tadalafil therapy for sarcoidosis-associated pulmonary hypertension.

Ford, H J; Baughman, R P; Aris, R; Engel, P; Donohue, J F

Ford, H J; Baughman, R P; Aris, R; Engel, P; Donohue, J F.

Afiliación

Ford HJ; Division of Pulmonary and Critical Care Medicine, University of North Carolina, Chapel Hill, North Carolina, USA.
Baughman RP; Division of Pulmonary and Critical Care Medicine, University of Cincinnati Hospitals, Cincinnati, Ohio, USA.
Aris R; Division of Pulmonary and Critical Care Medicine, University of North Carolina, Chapel Hill, North Carolina, USA.
Engel P; Pulmonary Hypertension Program, Christ Hospital, Cincinnati, Ohio, USA.
Donohue JF; Division of Pulmonary and Critical Care Medicine, University of North Carolina, Chapel Hill, North Carolina, USA.

Pulm Circ ; 6(4): 557-562, 2016 Dec.

Article en En | MEDLINE | ID: mdl-28090299

Palabras clave

pulmonary hypertension; sarcoidosis; tadalafil

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Pulm Circ Año: 2016 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google